Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications
Zbytovský, J.; Zapletálek, M.
Activitas Nervosa Superior 31(4): 266-267
1989
ISSN/ISBN: 0001-7604 PMID: 2638106 Document Number: 333965
Document emailed within 1 workday
Related Documents
Meyler, L. 1971: Undesired side effects of drugs Nederlands Tijdschrift Voor Geneeskunde 115(46): 1941-1943Leff, J.P.; Tress, K.H. 1986: The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate International Clinical Psychopharmacology 1(Suppl 1): 27-40
Bach, O.; Kästner, I. 1984: Undesired drug side effects and drug-induced damage. II. Centrally acting drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 1-6
Lagomarsino, A.J. 1987: Haloperidol decanoate in psychotic patients Acta Psiquiatrica y Psicologica de America Latina 33(3): 181
Zbytovský, J. 1993: Haloperidol decanoate (Janssen) in the treatment of schizophrenia Ceskoslovenska Psychiatrie 89(1): 27-29
Nalbanski, B. 1990: A comparative study of the efficacy, tolerance and side effects in using IUDs--the Copper T and Nova T--over a 3-year period Akusherstvo i Ginekologiia 29(2): 46-49
Paolucci, S.; Buttinelli, C.; Ciani, S.; Fiume, S. 1982: 2 cases of Gilles de la Tourette's disease treated with haloperidol decanoate Minerva Psichiatrica 23(1): 59-61
Ereshefsky, L.; Saklad, S.R.; Tran-Johnson, T.; Toney, G.; Lyman, R.C.; Davis, C.M. 1990: Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen Psychopharmacology Bulletin 26(1): 108-114
Ellerman, L.A. 1987: Open clinical trial with haloperidol decanoate in patients with psychotic disorders Acta Psiquiatrica y Psicologica de America Latina 33(2): 157-162
Roncoroni, D. 1984: Long-term therapy of chronic schizophrenic patients with haloperidol decanoate Psychiatrische Praxis 11(2): 56-58
Cesková, E.; Svestka, J.; Rysánek, R. 1993: Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses Ceskoslovenska Psychiatrie 89(1): 11-14
Smith, D.A. 1991: Psychiatric side effects of non-psychiatric drugs South Dakota Journal of Medicine 44(10): 291-292
Altamura, A.C.; Buccio, M.; Colacurcio, F.; Colombo, G.; Terzi, A. 1986: Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol Acta Neurologica 8(1): 19-26
Lecrubier, Y.; Soubrié, C.; Simon, P. 1981: Diagnosis of side effects applied to a particular area: psychiatry Therapie 36(3): 247-248
Dencker, S.J.; Elgen, K. 1980: Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics Acta Psychiatrica Scandinavica. Supplementum 279: 5-9
Pander Maat, H.; Klaassen, R. 1996: The effect of the wording of information about side effects on patients' interpretation of reported side effects Nederlands Tijdschrift Voor Geneeskunde 140(8): 424-427
Chandra, O.; Bernard, J.; Matussek, N. 1974: Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats Arzneimittel-Forschung 24(11): 1821-1824
1988: A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. I: Contraceptive efficacy and side effects Contraception (Stoneham) 37(1): 1-20
Castot, A.; Garnier, R.; Lanfranchi, C.; Bavoux, F. 1980: Systemic side effects of drugs applied cutaneously: report of a few cases in infants Therapie 35(3): 423-432
Chen, C.W. 1989: Adverse side effects caused by topically applied antiviral agents in herpetic keratitis Gaoxiong Yi Xue Ke Xue Za Zhi 5(8): 416-429